股本结构
单位：万股
| 公告日期 | 2024-04-15 | 2024-02-28 | 2024-02-28 | 2024-04-15 | 2023-12-18 | 2024-01-03 |
|---|---|---|---|---|---|---|
| 证券总股本 | 1372.94 | 750.51 | 684.64 | 170.12 | 170.12 | 165.13 |
| 普通股本 | 1372.94 | 750.51 | 684.64 | 170.12 | 170.12 | 165.13 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-04-09 | 2024-02-28 | 2024-01-25 | 2023-12-31 | 2023-12-01 | 2023-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-04-15 | 1372.94 | 未披露 | 定期报告 | 2024-04-09 |
| 2024-02-28 | 750.51 | 未披露 | 定期报告 | 2024-02-28 |
| 2024-02-28 | 684.64 | 未披露 | 定期报告 | 2024-01-25 |
| 2024-04-15 | 170.12 | 未披露 |
更多>>
From January 1, 2023 to December 31, 2023
Issuance of Common Stock to Pure Pressure
Reverse stock split fractional share settlement
Exercise of prefunded warrants in private placement
Proceeds from Employee Stock Purchase Plan Shares
Issuance of Common Stock through an “at the market” offering, net of fees
Issuance of held-back shares to Lab Society
Vesting of restricted stock units
Conversion of Exchange Note
Conversion of Convertible Note
|
2023-12-31 |
| 2023-12-18 | 170.12 | 未披露 | 定期报告 | 2023-12-01 |
| 2024-01-03 | 165.13 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Reverse stock split fractional share settlement
|
2023-09-30 |
| 2023-07-03 | 162.29 | 未披露 |
更多>>
Agrify Corporation announced that the Company’s Board of Directors approved a 1-for-20 reverse stock split, to be effective as of 12:01 a.m. on Wednesday, July 5, 2023.
|
2023-07-05 |
| 2023-02-06 | 2074.10 | 未披露 | 定期报告 | 2023-01-13 |
| 2022-12-16 | 2076.55 | 未披露 |
更多>>
Common stock offered 11,884,615 shares by the company
|
2022-12-20 |
| 2022-12-15 | 888.09 | 未披露 | 定期报告 | 2022-12-14 |
| 2022-11-14 | 887.64 | 未披露 | 定期报告 | 2022-11-10 |
| 2022-10-18 | 267.10 | 未披露 |
更多>>
Agrify Corporation announced that the Company’s Board of Directors approved a 1-for-10 reverse stock split, to be effective as of 12:01 a.m. on Tuesday, October 18, 2022.
|
2022-10-18 |
| 2022-10-17 | 2671.01 | 未披露 | 定期报告 | 2022-10-17 |
| 2022-09-19 | 2667.85 | 未披露 | 定期报告 | 2022-09-06 |
| 2022-08-15 | 2659.14 | 未披露 | 定期报告 | 2022-08-10 |
| 2022-08-15 | 2659.14 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Exercise of options
Exercise of warrants
|
2022-06-30 |
| 2022-05-16 | 2659.14 | 未披露 | 定期报告 | 2022-05-12 |
| 2022-04-29 | 2654.92 | 未披露 | 定期报告 | 2022-04-11 |
| 2022-05-16 | 2654.29 | 未披露 |
更多>>
From January 1, 2022 to March 31, 2022
Issuance of Common Stock and warrants in private placement
Acquisition of Lab Society
Exercise of options
Exercise of warrants
|
2022-03-31 |
| 2022-03-31 | 2654.29 | 未披露 | 定期报告 | 2022-03-24 |
| 2022-03-18 | 2654.29 | 未披露 | 定期报告 | 2022-03-14 |
| 2022-02-11 | 2479.73 | 未披露 | 定期报告 | 2022-02-11 |
| 2022-03-31 | 2220.71 | 未披露 |
更多>>
From January 1, 2021 to December 31, 2021
Conversion of Convertible Notes
Issuance of common shares in connection with acquisition
Issuance of common stock – Initial Public Offering ("IPO"), net of fees
Issuance of common stock – Secondary public offering, net of fees
Conversion of Preferred A Stock
Acquisition of Precision and Cascade
Acquisition of PurePressure
Exercise of options
Exercise of warrants
|
2021-12-31 |
| 2021-11-12 | 2127.10 | 未披露 | 定期报告 | 2021-11-09 |
| 2021-11-12 | 2126.14 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common shares in connection with acquisition
Exercise of options
Exercise of warrants
|
2021-09-30 |
| 2021-08-13 | 2055.84 | 未披露 | 定期报告 | 2021-08-10 |
| 2021-08-13 | 2037.37 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Exercise of options
|
2021-06-30 |
| 2021-05-17 | 2029.51 | 未披露 |
更多>>
From January 1, 2021 To March 31, 2021
Conversion of Convertible Notes
Issuance of common stock – Initial Public Offering (“IPO”), net of fees
Issuance of common stock – Secondary public offering, net of fees
Conversion of Preferred A Stock
Exercise of options
Exercise of warrants
|
2021-03-31 |
| 2021-04-02 | 2029.51 | 未披露 | 定期报告 | 2021-03-29 |
| 2021-03-22 | 2005.49 | 未披露 |
更多>>
1.The Underwriters exercised the over-allotment option, and on March 22, 2021, the Company closed on the sale of an additional 833,333 shares of common stock for a price of $13.50 per share, less a 7% underwriting commission.The exercise of the over-allotment option brings the total number of shares of common stock sold by the Company in connection with the Offering to 6,388,888 shares and the total net proceeds received in connection with the Offering to approximately $80 million, after deducting underwriting discounts and estimated offering expenses.
|
2021-03-22 |
| 2021-02-19 | 1922.16 | 未披露 |
更多>>
1.Common stock being offered by the company 5,555,555 shares.
|
2021-02-19 |
| 2021-02-11 | 1366.60 | 未披露 | 定期报告 | 2021-02-11 |
| 2021-02-04 | 1349.18 | 未披露 |
更多>>
1.The underwriters exercised the over-allotment option, and on February 4, 2021, the Company closed on the sale of an additional 810,000 shares of common stock for a price of $10.00 per share, less a 7% underwriting commission. The exercise of the over-allotment option brings the total number of shares of common stock sold by the Company in connection with the IPO to 6,210,000 shares and the total net proceeds received in connection with the offering to approximately $57 million, after deducting underwriting discounts and estimated offering expenses.
|
2021-02-04 |
| 2021-01-29 | 1268.18 | 未披露 |
更多>>
1.Common stock being offered by the company 5,400,000 shares
|
2021-01-28 |
From January 1, 2023 to December 31, 2023
Issuance of Common Stock to Pure Pressure
Reverse stock split fractional share settlement
Exercise of prefunded warrants in private placement
Proceeds from Employee Stock Purchase Plan Shares
Issuance of Common Stock through an “at the market” offering, net of fees
Issuance of held-back shares to Lab Society
Vesting of restricted stock units
Conversion of Exchange Note
Conversion of Convertible Note
From June 30, 2023 to September 30, 2023
Reverse stock split fractional share settlement
Agrify Corporation announced that the Company’s Board of Directors approved a 1-for-20 reverse stock split, to be effective as of 12:01 a.m. on Wednesday, July 5, 2023.
Common stock offered 11,884,615 shares by the company
Agrify Corporation announced that the Company’s Board of Directors approved a 1-for-10 reverse stock split, to be effective as of 12:01 a.m. on Tuesday, October 18, 2022.
From March 31, 2022 to June 30, 2022
Exercise of options
Exercise of warrants
From January 1, 2022 to March 31, 2022
Issuance of Common Stock and warrants in private placement
Acquisition of Lab Society
Exercise of options
Exercise of warrants
From January 1, 2021 to December 31, 2021
Conversion of Convertible Notes
Issuance of common shares in connection with acquisition
Issuance of common stock – Initial Public Offering ("IPO"), net of fees
Issuance of common stock – Secondary public offering, net of fees
Conversion of Preferred A Stock
Acquisition of Precision and Cascade
Acquisition of PurePressure
Exercise of options
Exercise of warrants
From June 30, 2021 to September 30, 2021
Issuance of common shares in connection with acquisition
Exercise of options
Exercise of warrants
From March 31, 2021 to June 30, 2021
Exercise of options
From January 1, 2021 To March 31, 2021
Conversion of Convertible Notes
Issuance of common stock – Initial Public Offering (“IPO”), net of fees
Issuance of common stock – Secondary public offering, net of fees
Conversion of Preferred A Stock
Exercise of options
Exercise of warrants
1.The Underwriters exercised the over-allotment option, and on March 22, 2021, the Company closed on the sale of an additional 833,333 shares of common stock for a price of $13.50 per share, less a 7% underwriting commission.The exercise of the over-allotment option brings the total number of shares of common stock sold by the Company in connection with the Offering to 6,388,888 shares and the total net proceeds received in connection with the Offering to approximately $80 million, after deducting underwriting discounts and estimated offering expenses.
1.Common stock being offered by the company 5,555,555 shares.
1.The underwriters exercised the over-allotment option, and on February 4, 2021, the Company closed on the sale of an additional 810,000 shares of common stock for a price of $10.00 per share, less a 7% underwriting commission. The exercise of the over-allotment option brings the total number of shares of common stock sold by the Company in connection with the IPO to 6,210,000 shares and the total net proceeds received in connection with the offering to approximately $57 million, after deducting underwriting discounts and estimated offering expenses.
1.Common stock being offered by the company 5,400,000 shares